IL6 and cancer: Furthermore, ω-3 PUFAs have been shown to modulate inflammatory cytokines, notably interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), both of which play pivotal roles in carcinogenesis and disease progression, supporting their potential therapeutic application in cancer management [10].